Wednesday, July 27 11:15 am – 11:45 am
During our webinar in April 2022, we discussed the role of molecular testing platforms, such as qPCR, ddPCR and NGS in enabling discovery and development of cell and gene therapy products. While these technologies are well-developed and well-supported in other areas of drug discovery and development, their presence in bioanalysis of cell and gene therapy products is a more recent development. This has resulted in many unanswered questions on the appropriate use of these technologies in the field of bioanalysis, especially due to the lack of prescriptive guidance. We will use a redacted and anonymized qPCR case study to answer some of the questions that frequently come up. We will then open the floor to discuss approaches to some common questions and requests.
Speaker: Stephanie Pasas-Farmer, Ph.D. Ariadne Software